This invention relates to a crystalline form of 14(2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea maleate, and topharmaceuticalcompositions thereof, to intermediates and methods for the production andisolation of suchcrystalline forms and compositions.